BIOLIFE SOLUTIONS INC Earnings Per Share Diluted

• BIOLIFE SOLUTIONS INC showed an increase of +77.3% in Earnings Per Share Diluted from 2024 to 2025.
• This data is from BIOLIFE SOLUTIONS INC's annual report (Form 10-K), filed with the SEC on February 26, 2026.
• XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Quarterly values from 10-Q filings: Q2 2017: $0.06 (loss) per share | Q3 2017: $0.03 (loss) per share | Q1 2018: $0.01 (loss) per share | Q2 2018: $0.05 per share | Q3 2018: $0.05 per share | Q1 2019: $1.03 (loss) per share | Q2 2019: $0.02 per share | Q3 2019: $0.35 per share | Q1 2020: $0.01 (loss) per share | Q2 2020: $0.70 (loss) per share | Q3 2020: $0.04 (loss) per share | Q1 2021: $0.03 (loss) per share | Q2 2021: $0.19 per share | Q3 2021: $0.00 per share | Q2 2022: $1.72 (loss) per share | Q3 2022: $0.24 (loss) per share | Q1 2023: $0.32 (loss) per share | Q2 2023: $0.23 (loss) per share | Q3 2023: $0.67 (loss) per share | Q1 2024: $0.22 (loss) per share | Q2 2024: $0.45 (loss) per share | Q3 2024: $0.04 (loss) per share | Q1 2025: $0.01 (loss) per share | Q2 2025: $0.33 (loss) per share | Q3 2025: $0.01 per share.
• Over the full 9 years of available data (2017 to 2025), BIOLIFE SOLUTIONS INC's Earnings Per Share Diluted has grown by 52.4%.
• Historical annual values: Fiscal year 2025: $0.10 (loss) per share | Fiscal year 2024: $0.44 (loss) per share | Fiscal year 2023: $1.55 (loss) per share | Fiscal year 2022: $3.25 (loss) per share | Fiscal year 2021: $0.23 (loss) per share | Fiscal year 2020: $0.06 (loss) per share | Fiscal year 2019: $0.09 (loss) per share | Fiscal year 2018: $0.14 per share | Fiscal year 2017: $0.21 (loss) per share.
• Data sourced from SEC EDGAR public filings as of August 10, 2026.

Last verified: August 10, 2026